Loading
Latest filing published 24 May 2022 for PhaseBio Pharmaceuticals Inc, €13k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 24 May 2022, Jonathan Birchall disclosed a share grant of €13k in PhaseBio Pharmaceuticals Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration